Nutrien (NYSE: NTR) reported Q2 EPS of $2.53, $0.30 worse than the analyst estimate of $2.83.

The company guided:

Based on market factors detailed above, we are revising full-year 2023 adjusted EBITDA guidance1 to $5.5 to $6.7 billion and full-year 2023 adjusted net earnings guidance1 to $3.85 to $5.60 per share. We now project cash provided by operations of $4.4 to $4.9 billion, which reflects expectations of lower earnings.

For earnings history and earnings-related data on Nutrien (NTR) click here.